T3	Subject 43 52	a patient
T4	Effect 0 39	Primary central nervous system lymphoma
T5	Treatment 66 77	natalizumab
T7	Drug 66 77	natalizumab
T6	Adverse_event 53 60	treated
E1	Adverse_event:T6